Pennington Partners & Co »

Cytokinetics shares owned by Pennington Partners & Co

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Pennington Partners & Co from 13F filings

Historical chart of Pennington Partners & Co investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Pennington Partners & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Pennington Partners & Co

Quarter filed Position value Share count Share price at filing
2025-12-31 $208k 3.3k 63.54

More positions owned by Pennington Partners & Co

Vanguard Index Fds Total Stk Mkt (VTI)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Ishares Tr Russell 3000 Etf (IWV)
Vanguard Scottsdale Fds Vng Rus3000idx (VTHR)
Vanguard World Esg Us Stk Etf (ESGV)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Msci Acwi Etf (ACWI)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Lineage (LINE)
Amazon (AMZN)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
NVIDIA Corporation (NVDA)

View all positions for Pennington Partners & Co

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
State Street Corporation
Deep Track Capital
Geode Capital Management
Susquehanna International
Rtw Investments
Goldman Sachs Group
Polar Capital Holdings
Armistice Capital
Integral Health Asset Management
Citadel Advisors

View all funds holding Cytokinetics